Antimicrobial Peptides
A section of Antibiotics (ISSN 2079-6382).
Section Information
One of the major challenges of the 21st century in biological sciences is the discovery of new molecules with antimicrobial properties and active on bacterial strains that are multi-resistant to the antibiotics currently available in our therapeutic arsenal. Peptides are a family of molecules that are capable of acting effectively against such bacteria—in particular those responsible for nosocomial diseases such as the methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase-producing Enterobacteriaceae. Interestingly, antibacterial peptides are part of the arsenal of host defense peptides that are present in a variety of simple and complex life forms, from prokaryotes (e.g., bacteriocins) to eucaryotes (e.g., defensins, cathelicidins). Due to their particular antibacterial potential, they are currently emerging as solid candidate therapeutic compounds against both pathogenic Gram-positive and Gram-negative bacteria, including those resistant to ‘conventional’ antibiotics. Many applications of antimicrobial peptides do exist in various fields, including human and animal health, feeding, agriculture and cosmetic/dermatologic fields.
The Section ‘Antimicrobial Peptides’ of the journal Antibiotics focuses on the various aspects of antibacterial/antimicrobial peptides from natural (e.g., animal venoms, milk) or non-natural sources (synthetic de novo designed peptides), from their discovery to the structural and functional characterization, the mode of action at a molecular level, as well as the development and evaluation in clinical trials. Potential contributors are strongly encouraged to submit their best work(s) in this important emerging field of applied scientific research.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Reviews on Antimicrobial Peptides (Deadline: 31 March 2023)
- The Century-Long Journey of Peptide-Based Drugs (Deadline: 30 April 2023)
- Insights on Antimicrobial Peptides and Peptidomimetics, and Their Antimicrobial Potential (Deadline: 30 April 2023)
- Computational Approaches in Discovery & Design of Antimicrobial Peptides (Deadline: 30 April 2023)
- Antimicrobial Peptides from Natural Sources to Synthetic Optimization (Deadline: 30 June 2023)
- Antimicrobial Activity and Mechanisms of Action of Peptides (Deadline: 30 June 2023)
- Membranes to Fight Drug-Resistant Microbes (Deadline: 30 June 2023)
- Accelerating the Discovery and Characterization of Antimicrobial Peptides (Deadline: 30 June 2023)
- Antimicrobial Peptides Fighting against Bacterial Infections (Deadline: 31 July 2023)
- Editorial Board Members' Collection Series: Structural Aspects of AMPs and Antimicrobials (Deadline: 31 July 2023)
- Potential of Antimicrobial Peptides for an Exciting Future (Deadline: 31 August 2023)
- Design, Synthesis, and Application of Antimicrobial Peptides (Deadline: 15 September 2023)
- Design, Modification and Application of Antimicrobial Peptides (Deadline: 30 September 2023)
- The Role of Antimicrobial Peptides in Tackling Antimicrobial Resistance (Deadline: 30 November 2023)
- Bioactive Peptides and Their Antibiotic Activity (Deadline: 31 December 2023)
- Discovery and MultiFunctionality of Anti-Microbial Peptides (Deadline: 31 December 2023)